Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Baby ABS (Abdominal Binder Study)

NCT: NCT07049900 · RECRUITING

NCT IDNCT07049900
StatusRECRUITING
Start Date2025-01-22
Completion2027-04-30
SponsorUniversity of Minnesota (OTHER)
First posted
Last updated

Brief Summary

The primary outcome of this study is to determine if the use of the FDA-approved DandleLion NeoBellyBand increases the thickness of the rectus abdominis muscle in premature babies receiving continuous positive pressure ventilation, leading to infants reaching full oral feedings at an earlier corrected gestational age.

Frequently Asked Questions

What is Baby ABS (Abdominal Binder Study)?

Baby ABS (Abdominal Binder Study) is a clinical trial registered under NCT07049900. Current status: RECRUITING.

What is the status of NCT07049900?

The current status of NCT07049900 (Baby ABS (Abdominal Binder Study)) is: RECRUITING.

When did Baby ABS (Abdominal Binder Study) start?

Baby ABS (Abdominal Binder Study) started on 2025-01-22.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.